Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

CYTKCYTK
Showing 8 of 14 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in CYTOKINETICS INC

WELLINGTON MANAGEMENT GROUP LLP holds 8M shares of CYTK (CYTOKINETICS INC), worth $527.9M as of 2026-Q1. The position was increased (+0.9% shares). CYTK represents 0.1% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$527.9M

Current Shares

8M

Total Value Change

+$121M

Total Shares Change

+499,959

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
8M
+0.9%
$527.9M0.1%$60.72
32
2025-Q4
Increased
7.9M
+7.1%
$504.3M0.1%$61.37
34
2025-Q3
Decreased
7.4M
-5.3%
$407.2M0.1%$53.89
0
2025-Q2
Decreased
7.8M
-2.0%
$258.6M0.0%$33.16
0
2025-Q1
Increased
8M
+1.3%
$321.1M0.1%$43.19
31
2024-Q4
Increased
7.9M
+1.5%
$371.1M0.1%$47.15
31
2024-Q3
Increased
7.8M
+3.5%
$410.5M0.1%$52.34
32
2024-Q2
Increased
7.5M
+88.6%
$406.9M0.1%$54.18
49

Other major holders of CYTK: BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used